Physician profile
Michael Schwartz
NPI 1831109677
$1,486.78
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $65.05 · 2021: $95.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $261.98 | 2019 | |
| Ucb, INC. | $186.32 | 2019 | |
| Biogen, INC. | $132.80 | 2019-2020 | |
| Emd Serono, INC. | $130.50 | 2019 | |
| Acorda Therapeutics, INC | $129.76 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $116.73 | 2019-2021 | |
| Abbvie INC. | $103.58 | 2019-2021 | |
| Genzyme Corporation | $63.55 | 2019 | |
| Amgen INC. | $54.43 | 2019 | |
| Lilly USA, LLC | $53.61 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $37.84 | 2019 | |
| Livanova USA, INC. | $31.27 | 2019 | |
| Pfizer INC. | $23.57 | 2019 | |
| Mdd US Operations, LLC | $23.56 | 2019 | |
| Akcea Therapeutics, INC. | $20.25 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $20.00 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.82 | 2019 | |
| Acadia Pharmaceuticals INC | $14.82 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.41 | 2019 | |
| Genentech USA, INC. | $14.19 | 2019 | |
| Genentech, INC. | $13.45 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.61 | 2019 | |
| Allergan, INC. | $11.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.